col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


101 Results       Page 1

 [1] 
Elsevier: Vacunas
  original article Date Title Authors   All Authors
1 [GO] 2023―Sep―15 Vacunación frente al SARS-CoV-2 en otoño de 2023: ¿a quién y cómo hay que vacunar? Fernando Moraga-Llop, Magda Campins-Martí
2 [GO] 2023―Aug―31 COVID-19 vaccines, perceptions and trust amongst vaccine refusers: A qualitative thematic analysis study Deldar Morad Abdulah, Hawar Abdulrazaq Mohammedsadiq, Pranee Liamputtong
3 [GO] 2023―Aug―30 To assess mortality from COVID-19 in patients with comorbidities, it is crucial to perform an autopsy Josef Finsterer
4 [GO] 2023―Jun―29 Exploring the Intention and Hesitancy to Receive a Booster Dose of COVID-19 Vaccine among Patients with Comorbid Disease Conditions Using a Health Belief Model. Anmar AL-TAIE, Zekiye K. YILMAZ
5 [GO] 2023―Jun―24 Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria Alejandro de Arriba Fernández, José Luis Alonso Bilbao, Alberto Espiñeira Francés, Antonio Cabeza Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros
6 [GO] 2023―May―26 Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece. Petros Galanis, Aglaia Katsiroumpa, Irene Vraka, Vanessa Chrysagi, Olga Siskou, Olympia Konstantakopoulou, et al. (+3)
7 [GO] 2023―May―18 ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION AMONG PREGNANT WOMEN ATTENDING PRIMARY HEALTH CENTERS: AN ACTIVE-SURVEILLANCE STUDY. Narayana Goruntla, Basappa Karisetty, N. Nandini Reddy, Bharadwaj Bhupasamdram, Himaja Reddy Ganireddy, Kasturi Vishwanathasetty Veerabhadrappa, et al. (+2)
8 [GO] 2023―May―18 COVID-19 Immune Response In Adults Post Measles-Rubella Vaccination. Suwoyo Suwoyo, Erna Rahma Yani, Koekoeh Hardjito
9 [GO] 2023―May―18 El fin de la urgencia internacional de salud pública por COVID-19: ¿y ahora qué? Núria Torner
10 [GO] 2023―May―04 Impact of Vaccination on the Entire Population and Dose-Response Relation of COVID-19 Abdul Malek, Ashabul Hoque
11 [GO] 2023―Apr―25 The status of COVID-19 vaccines in India: A Review. Deepak Kumar Jha, Kumar Pranay, Amit Kumar, Niti Yashvardhini
12 [GO] 2023―Apr―10 The Polymorphisms of TNF-α Related-gene and Antibody Production Following Third Dose of COVID-19 Vaccination: A Pilot Study. Phey Liana, Zen Hafy, Soilia Fertilita, Ella Amalia, Veny Larasati, Tungki Pratama Umar
13 [GO] 2023―Mar―06 IMPACTO DE LA VACUNACIÓN CONTRA SARS-CoV-2 EN LA INCIDENCIA DE INFECCIÓN EN ÁMBITO ESCOLAR. María Teresa Herrero Diez, María Inés Salado Valdivieso, Sara Carbajal Domínguez, Marta Allué Tango, Juan Carlos Villa Caballero, Clara Berbel Hernández
14 [GO] 2023―Mar―02 An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13. Sushant Kumar, Khushboo Kumari, Gajendra Kumar Azad
15 [GO] 2023―Feb―13 Demographic and clinical characteristics and outcomes of COVID-19 patients admitted to a university hospital in the west of Iran: a retrospective study in the third wave. Younes Jesmani, Arezoo Bozorgomid, Fatemeh Khosravi Shadmani, Ali Dehbani, Babak Sayad
16 [GO] 2023―Jan―25 Incidence of sudden sensorineural hearing loss associated with BNT162b2 COVID-19 vaccine: Pooled results from register-based nationwide studies Paulo Ricardo Martins-Filho
17 [GO] 2023―Jan―17 FACTORES ASOCIADOS A LA INTENCIÓN DE VACUNACIÓN CONTRA EL COVID-19, EN POPAYÁN, CAUCA COLOMBIA Omar Andrés Ramos Valencia, Yuliana Buitrón Gonzalez, Jorge Sotelo Daza, Andrés Felipe Villaquiran
18 [GO] 2022―Dec―27 Optic neuritis associated with COVID-19-related vaccines Masoud Keikha, Mehdi Zandhaghighi, Shahram Shahraki Zahedani
19 [GO] 2022―Dec―26 Vacunación frente a la COVID-19 a partir de los 6 meses de edad. Completando el círculo de la prevención en pediatría. Fernando Moraga-Llop
20 [GO] 2022―Dec―13 Knowledge And Attitudes Toward the COVID-19 Vaccine Among India's General Rural Population Rajesh Venkataraman, Umesh Yadav, Yogendra Shrestha, Sindhu Shree Narayanaswamy, Shree Harsha Pura Basavaraju
21 [GO] 2022―Nov―04 Determination of Binding Affinity of Tunicamycin with SARS-CoV-2 Proteins: Proteinase, Protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, Envelope and RBD of Spike Glycoprotein Ali Adel Dawood
22 [GO] 2022―Nov―01 The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19 Ali AliMohammadi, Nahid Chazani-Sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati, Ehsanollah Ghaznavi-Rad
23 [GO] 2022―Nov―01 Differences in elderly stress levels before Covid-19 vaccination: History of exposure to Covid-19 reduces stress before vaccination Kristian Budi Setiawan, Isna Hikmawati, Dita Pratiwi Kusuma Wardani, Juanita Juanita
24 [GO] 2022―Oct―19 IR-7968. Enfermedad invasiva por neumococo en 2021. Impacto de la pandemia de COVID-19 C. Izquierdo Gómez, N. Soldevila Pidemunt, J. García-García, B. Viñado, A. Díaz-Conradi, Grupo de trabajo Barcino
25 [GO] 2022―Oct―19 IE-7919. Reticencias vacunales COVID-19 M.C. Gómez Moreno, M.B. Laorden Ochando, S. Sánchez Manresa, M. Pérez Martínez, M. Zornoza Moreno, J.J. Pérez Martín
26 [GO] 2022―Oct―19 IE-7884. Inmunogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como refuerzo heterólogo en individuos previamente vacunados contra la COVID-19 S. de Cambra Florensa, J. Corominas Garia, M.T. Prat Cabañas, E. Torroella Busquets
27 [GO] 2022―Oct―19 IE-7881. Reactogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como refuerzo heterólogo: diferencias según la vacunación primaria previamente recibida y según el historial de infección de COVID-19 C. Borralleras Fumaña, J. Corominas García, M.T. Prat Cabañas, L. Ferrer Soler, I. Güell Casellas, E. Torroella Busquets
28 [GO] 2022―Oct―19 IE-7717. Los Servicios de Urgencias como aliados en la notificación de sospecha de reacciones adversas asociadas a la vacunación COVID-19 I. González-Iglesias, M. Fernández-Prada, E. Martín-Aragonés, P. Penanes-Alonso, P. Cienfuegos-González, M.J. Zapico-Baragaño
29 [GO] 2022―Oct―19 IR-7922. Comparación de 2 brotes de COVID-19 acaecidos antes y después de la vacunación de usuarios y trabajadores de una residencia geriátrica G. Parisé Farreny, J. Rosinach Bonet, N. Rosell Solé, J.P. Bamala Zuriguel, I. Mòdol Pena, X. Farré Pueyo
30 [GO] 2022―Oct―19 EE-7888. Campaña de captación (catch-up) con COVID-19 en gestantes: implementación y resultados M. Fernández-Prada, A. Sánchez del Río, C.I. González-González, E. Martín-Aragonés, L. López-Fernández, P. Cienfuegos-González
31 [GO] 2022―Oct―19 ER-7932. Experiencia de vacunación frente al COVID-19 en las personas de muy alto riesgo en el Servicio de Medicina Preventiva y Salud Pública de un hospital de tercer nivel N. Manrique Vinagre, M.M. Guerra Hernández, V. Fernández Espinilla, N. Khynku Khshyva, C. De Álvaro García, M. Martínez Retortillo
32 [GO] 2022―Oct―19 IR-7936. Características epidemiológicas de las reinfecciones por COVID-19 en los trabajadores sanitarios A. Pérez Dalí, R. García Rodríguez, M.J. Pereira Rodríguez, I. Díaz Vázquez, F. Freijedo Fariñas, M.M. Castro Rivas
33 [GO] 2022―Oct―19 EE-7853. Campaña de captación (catch-up) con COVID-19 en pacientes hospitalizados: implementación y resultados P. Cienfuegos-González, E. Madrid-Álvarez, M. Fernández-Prada, M.J. Zapico-Baragaño, E. Martín-Aragonés, L. López-Fernández
34 [GO] 2022―Oct―19 ER-7972. Características de los profesionales vacunados frente al COVID-19 en un hospital de tercer nivel E. García Carrasco, D.M. López Garizado
35 [GO] 2022―Oct―19 EE-7978. Implementación de la campaña de vacunación frente a COVID-19 en un hospital de tercer nivel L.P. Cabrera-Miranda, A. García De Codes Ilario, S. de Miguel García, N. Rosillo Ramírez, E.M. Medrano Monteagudo, M.P. Gil Martínez, M.P. Arrazola Martínez
36 [GO] 2022―Oct―19 IE-7971. Perfil clínico y demográfico de los pacientes candidatos a recibir Evusheld® para la prevención de la COVID-19 grave, en un hospital de tercer nivel E. García Verduguez, N. Rosillo Ramírez, S. de Miguel García, A. García de Codes, L.P. Cabrera Miranda, P. Arrazola Martínez
37 [GO] 2022―Oct―19 IR-7641. Cobertura vacunal antineumocócica en pacientes mayores de 65 años hospitalizados por la enfermedad de SARS-CoV-2 M.T. Herrero Díez, M.M. Guerra Hernández, V. Fernández Espinilla, M.C. Viña Simón, C. Hernán García, J.J. Castrodeza Sanz
38 [GO] 2022―Oct―19 IE-7951. Evolución epidemiológica de los nuevos serotipos vacunales 22F y 33F de Streptococcus pneumoniae en España incluyendo el impacto de la pandemia por SARS-CoV-2 J. Sempere, S. Ruiz, D. Rico, S. de Miguel, M. Domenech, J. Yuste
39 [GO] 2022―Oct―19 IE-7950. Contribución de las vacunas conjugadas antineumocócicas y el SARS-CoV-2 a la resistencia a antibióticos en Streptococcus pneumoniae en España durante el periodo 2004-2020 J. Sempere, C. Pérez-García, D. Lago, S. Hita, M. Domenech, J. Yuste
40 [GO] 2022―Oct―19 IE-7967. Respuesta a la vacunación frente a SARS-CoV-2 con vacunas de ARNm en los pacientes inmunodeprimidos N. Rosillo Ramírez, A. García de Codes, L.P. Cabrera Miranda, S. de Miguel García, E. García Verduguez, P. Arrazola Martínez
41 [GO] 2022―Oct―19 IE-7925. Contribución de las vacunas antineumocócicas y la pandemia por SARS-CoV-2 en la evolución epidemiológica de la enfermedad neumocócica invasiva en España S. de Miguel, J. Sempere, S. Hita, J. Llorente, M. Domenech, J. Yuste
42 [GO] 2022―Oct―19 IR-7885. Seguridad de una vacuna de proteína recombinante basada en un heterodímero de fusión del dominio de unión al receptor del SARS-CoV-2 (PHH-1V) como primovacunación en adultos sanos en Vietnam S. de Cambra Florensa, C. Garriga Alsina, L. Ferrer Soler, E. Torroella Busquets
43 [GO] 2022―Oct―19 IR-7883. Inmunogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como primovacunación en adultos sanos en Vietnam C. Borralleras Fumaña, C. Garriga Alsina, L. Ferrer Soler, E. Torroella Busquets
44 [GO] 2022―Oct―04 Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study Fazlollah Shokri, Saeed Rezapoor, Masoud Najafi, Mohsen Asadi, Mohammad Karimi alavije, Moussa Abolhassani, et al. (+9)
45 [GO] 2022―Sep―16 Vaccine hesitancy and the challenge of controlling COVID-19 and other vaccine-preventable diseases Paulo Ricardo Martins-Filho
46 [GO] 2022―Aug―30 Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study Seyede Faezeh Mousavi, Mohammadamin Ebrahimi, Seyed Amirhosein Ahmadpour Moghaddam, Narges Moafi, Mahbobe Jafari, Ayoub Tavakolian, Mohsen Heidary
47 [GO] 2022―Aug―30 Parents' perception of COVID-19 risk of infection and intention to vaccinate their children Hamdy Khaled Sabra, Mostafa Abdulraheem Bakr, Omar El Sayed Mohmed Rageh, Asmaa Khaled, Omnia Mohamed Elbakliesh, Ibrahim Ali Kabbash
48 [GO] 2022―Jul―19 Vacunaciones masivas contra el COVID-19 mediante el uso de las tecnologías para la gestión de la programación de citas y datos de grandes volúmenes de vacunados Alicia K. Rodas-Martinez, Josue R. Altamirano-Yupanqui
49 [GO] 2022―Jul―19 Menstrual abnormalities after COVID-19 vaccines: A systematic review Maheen Nazir, Shumaila Asghar, Muhammad Ali Rathore, Asima Shahzad, Anum Shahid, Alishba Ashraf Khan, et al. (+4)
50 [GO] 2022―Jul―04 Reasons for Individuals' COVID-19 vaccine hesitations and changing decisions over time: A longitudinal qualitative study Dicle Filiz Yıldırım, Pınar Serçekuş, Sevgi Özkan
51 [GO] 2022―Jun―22 COVID-19 Vaccines: Update of the vaccines in use and under development Rafaela Angotti Marta, Gisele Emy Kondo Nakamura, Bruno de Matos Aquino, Paulo R. Bignardi
52 [GO] 2022―Jun―20 COVID-19 vaccination acceptance in Jambi City, Indonesia: A single vaccination Center study Gilbert Sterling Octavius, Theo Audi Yanto, Rivaldo Steven Heriyanto, Haviza Nisa, Catherine Ienawi, H. Emildan Pasai
53 [GO] 2022―Jun―17 Multivalent vaccines against new SARS-CoV-2 hybrid variants Kiarash Ghazvini, Masoud Keikha
54 [GO] 2022―Jun―17 Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? Masoud Keikha
55 [GO] 2022―Jun―09 Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants Ali Adel Dawood
56 [GO] 2022―Jun―03 Early diagnosis and treatment of SARS-CoV-2 vaccination associated polyradiculitis to improve the outcome Josef Finsterer, Fulvio A. Scorza
57 [GO] 2022―Jun―01 Comparison of clinical, radiological and laboratory findings in discharged and dead patients with COVID-19 Mahbobe Jafari, Maryam Akbari, Maryam Navidkia, Shirin Dashtbin, Seyede Faezeh Mousavi, Mohsen Heidary, Saeed Khoshnood
58 [GO] 2022―Jun―01 COVID-19 vaccination coverage and associated factors in seasonal fruit workers in Lleida Carme Miret, Miquel Alsedà, Pere Godoy
59 [GO] 2022―May―30 Risks of adverse outcomes in COVID-19 patients and vaccination status in a secondary hospital in Spain Christine Giesen, Carmen Saa-Requejo, Inmaculada Lopez-Carrillo, Angelica Ortega-Torres, Cristina García-Fernández
60 [GO] 2022―May―13 Intention to get COVID-19 vaccination and its associated predictors: A cross-sectional study among the general public in Algeria Mohamed Lounis, Samir Abdelhadi, Mohammed Amir Rais, Djihad Bencherit, Malik Sallam
61 [GO] 2022―Apr―28 Cross-sectional assessment of predictors for COVID-19 vaccine uptake: an online survey in Greece Petros Galanis, Irene Vraka, Olga Siskou, Olympia Konstantakopoulou, Aglaia Katsiroumpa, Ioannis Moisoglou, Daphne Kaitelidou
62 [GO] 2022―Apr―28 Lack of COVID-19 vaccination in rural areas of Pakistan Alisha Saleem, Maha Rashid, Ameerah Shaikh, Sajjad Ali
63 [GO] 2022―Mar―24 The prevalence of inverse health consequences of COVID-19 vaccines: a post-vaccination study Yogendra Shrestha, Rajesh Venkataraman
64 [GO] 2022―Feb―14 Evaluación de la respuesta de anticuerpos IGG específicos contra SARS-COV-2 en personal de salud con esquema completo de vacuna sputnik V (GAM-COVID-VAC) Ezequiel Cordova, M. Ines Lespada, Diego Cecchini, Fabiola Nieto, Susana Palonski, Mariana Badran, et al. (+8)
65 [GO] 2022―Feb―11 Vacunación pediátrica frente a la COVID-19 más allá de la adolescencia. Otra realidad F. Moraga-Llop
66 [GO] 2022―Feb―02 Awareness, knowledge and acceptance of COVID-19 vaccine among the people of West Bengal, India: A web-based survey Sovan Samanta, Jhimli Banerjee, Suvrendu Sankar Kar, Kazi Monjur Ali, Biplab Giri, Amitava Pal, Sandeep Kumar Dash
67 [GO] 2022―Jan―26 Adenoviral vector-based COVID-19 vaccines-associated cerebral venous sinus thromboses: Are those adverse events related to the formation of neutrophil extracellular traps? Marian Simka
68 [GO] 2022―Jan―25 La GESTIÓN de la PANDEMIA de COVID-19 EN las RESIDENCIAS GERIÁTRICAS de CATALUÑA F.E.R.N.A.N.D.O. PARRILLA
69 [GO] 2022―Jan―06 Selection of new COVID-19 genotypes following mass vaccination: The Rotavirus model Pierfrancesco Lapolla, Pietro Familiari, Placido Bruzzaniti
70 [GO] 2021―Dec―03 Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies Niti Yashvardhini, Amit Kumar, Deepak Kumar Jha
71 [GO] 2021―Nov―04 Asociación entre la vacunación contra influenza y la mortalidad por COVID-19 Cesar A Arce-Salinas, Yamile N Esquivel-Torruco, Arely A Bejarano-Juvera, Aditi K Bustamante- Flores, Naomi Aguilar-Martínez, Jessica G Azcorra- López, et al. (+4)
72 [GO] 2021―Nov―04 Is there any effect of flu vaccine on the SARS-CoV-2 infected patients? D. El-Qutob, M. Nieto, L. Alvarez-Arroyo, FJ Carrera-Hueso
73 [GO] 2021―Sep―07 Zinc role in Covid-19 disease and prevention Alberto Boretti, Bimal K Banik
74 [GO] 2021―Sep―07 Assessment of attitude and hesitancy towards vaccine against COVID-19 in a Pakistani population: A mix methods survey Zainab Aqeel Khan, Raheel Allana, Irrum Afzal, Akbar Shoukat Ali, Omama Mariam, Reema Aslam, et al. (+8)
75 [GO] 2021―Sep―07 Predictive demographic factors of Covid-19 vaccine hesitancy in Venezuela: a cross-sectional study Gabriel Andrade
76 [GO] 2021―Sep―06 Attitudes of a Sample of Jordanian Young Adults toward Different Available COVID-19 Vaccines Walid Al-Qerem, Anan S Jarab, Raghda Qarqaz, Mohammad Al Hayek
77 [GO] 2021―Sep―01 Factors influencing the acceptability of COVID-19 vaccination: A cross-sectional study from Malaysia Roy Rillera Marzo, Absar Ahmad, Khadijah Abid, Asmita Priyadashini Khatiwada, Ali Ahmed, Thin Mon Kyaw, et al. (+5)
78 [GO] 2021―Aug―04 COVID-19 and primary care: a perspective from Italy F Ghidinelli, F Martire
79 [GO] 2021―Aug―04 Disposición a recibir la vacuna contra COVID-19 en población de 80 y más años en Colombia 2021 Nelson Alvis-Guzman
80 [GO] 2021―Jul―13 Diagnosis Of Covid-19 In Symptomatic Patients: An Updated Review MN Zahan, H. Habibi, A. Pencil, J. Abdul-Ghafar, SA Ahmadi, NS Juyena, et al. (+2)
81 [GO] 2021―Jul―13 Variantes de SARS-CoV-2, una historia todavía inacabada Marta Pérez-Abeledo, Juan Carlos Sanz
82 [GO] 2021―Jun―17 Discordant results of SARS-CoV-2 PCR-based tests in the early phase of pandemic in Indonesia: infection control consequences Agung Pranata, Baidillah Zulkifli, Sukmawan Fajar Santosa, Ade Oktiviyari, Zulfitri Zulfitri, Zinatul Hayati, et al. (+3)
83 [GO] 2021―May―28 Vacunación frente a la COVID-19 en los adolescentes. Una realidad Fernando Moraga-Llop
84 [GO] 2021―May―19 “Recomendaciones SEPAR y nuevos retos sobre la vacuna COVID-19 en las enfermedades respiratorias” David de la Rosa-Carrillo, José Luis López-Campos, Marina Blanco Aparicio, Felipe Villar-Álvarez
85 [GO] 2021―Apr―15 Los gobiernos y la vacunación contra la COVID-19 Mag Luz Javier
86 [GO] 2021―Apr―09 Impacto de las variantes genéticas de la espícula en las vacunas frente al SARS-CoV-2 Jordi Reina, Pablo Fraile-Ribot
87 [GO] 2021―Apr―05 Retrospective and prospective application of robots and artificial intelligence in global pandemic and epidemic diseases A. Yoganandhan, G. Rajesh Kanna, S.D. Subhash, J. Hebinson Jothi
88 [GO] 2021―Mar―12 Myths and conspiracy theories on vaccines and COVID-19: Potential effect on global vaccine refusals Irfan Ullah, Kiran Shafiq Khan, Muhammad Junaid Tahir, Ali Ahmed, Harapan Harapan
89 [GO] 2021―Feb―26 The Vaccine-Condition Or Vaccination Passport And Its Eventual Fit Into A Broad Recommended Vaccination Framework Against Covid-19 César Cierco Seira
90 [GO] 2021―Jan―22 The role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic Alessandra La Gatta, Federico Ghidinelli
91 [GO] 2020―Nov―25 Mareo al volar irresoluble asociado a la infección por COVID-19: caso clínico Hamze Shahali, Amin Talebi Bezmin Abadi, Azade Amirabadi Farahani, Mohammad Darvishi
92 [GO] 2020―Oct―14 ¿Cómo será la segunda ola del terrible COVID-19 con el número creciente de casos infectados y mortalidad en Iraq? Ali Adel Dawood, Zahra Adel Dawood
93 [GO] 2020―Oct―14 Novel Coronavirus 2019 (COVID-19) Pandemic Outbreak: A Comprehensive Review of the Current Literature Hayat Ullah, Asad Ullah, Anbareen Gull, Tayyaba Mousavi, Muhammad Waseem Khan
94 [GO] 2020―Oct―03 Glicosilación, sitios de unión de ligandos y variaciones antigénicas entre la glicoproteína de membrana del COVID-19 y los coronavirus asociados Ali Adel Dawood
95 [GO] 2020―Sep―14 Tendencias epidémicas en los diez principales países con más casos de COVID-19 en comparación con Turquía Veli Durmuş
96 [GO] 2020―Sep―12 Are social distancing, hand washing and wearing masks can mitigate the transmission of COVID-19? Natesan Manikandan
97 [GO] 2020―Jul―04 Recuperando las coberturas vacunales perdidas en la pandemia COVID-19 F.A. Moraga-Llop, M. Fernández-Prada, A.M. Grande-Tejada, L.I. Martínez-Alcorta, D. Moreno-Pérez, J.J. Pérez-Martín
98 [GO] 2020―Jul―04 Collateral effects of Covid-19 pandemic emergency response on worldwide immunizations Nuria Torner
99 [GO] 2020―Jun―13 A review on Promising vaccine development progress for COVID-19 disease Tafere Mulaw Belete
100 [GO] 2020―Apr―18 Vacunas contra el coronavirus L. Urbiztondo, E. Borras, G. Mirada
101 [GO] 2020―Apr―04 El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo J. Reina
 [1] 

101 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.015 sec